Therapeutic enhancement of a cytotoxic agent using photochemical internalisation in 3D compressed collagen constructs of ovarian cancer
Source abstract
Abstract
Photochemical internalisation (PCI) is a method for enhancing delivery of drugs to their intracellular target sites of action. In this study we investigated the efficacy of PCI using a porphyrin photosensitiser and a cytotoxic agent on spheroid and non-spheroid compressed collagen 3D constructs of ovarian cancer versus conventional 2D culture. The therapeutic responses of two human carcinoma cell lines (SKOV3 and HEY) were compared using a range of assays including optical imaging. The treatment was shown to be effective in non-spheroid constructs of both cell lines causing a significant and synergistic reduction in cell viability measured at 48 or 96 h post-illumination. In the larger spheroid constructs, PCI was still effective but required higher saporin and photosensitiser doses. Moreover, in contrast to the 2D and non-spheroid experiments, where comparable efficacy was found for the two cell lines, HEY spheroid constructs were found to be more susceptible to PCI and a lower dose of saporin could be used. PCI treatment was observed to induce death principally by apoptosis in the 3D constructs compared to the mostly necrotic cell death caused by PDT. At low oxygen levels (1%) both PDT and PCI were significantly less effective in the constructs. STATEMENT OF SIGNIFICANCE: Assessment of new drugs or delivery systems for cancer therapy prior to conducting in vivo studies often relies on the use of conventional 2D cell culture, however 3D cancer constructs can provide more physiologically relevant information owing to their 3D architecture and the presence of an extracellular matrix. This study investigates the efficacy of Photochemical Internalisation mediated drug delivery in 3D constructs. In 3D cultures, both oxygen and drug delivery to the cells are limited by diffusion through the extracellular matrix unlike 2D models, and in our model we have used compressed collagen constructs where the density of collagen mimics physiological values. These 3D constructs are therefore well suited to studying drug delivery using PCI. Our study highlights the potential of these constructs for identifying differences in therapeutic response to PCI of two ovarian carcinoma lines.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Nanoplatforms for cancer theranostics · Cancer Cells and Metastasis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. The disparate origins of ovarian cancers: pathogenesis and prevention strategies10.1038/nrc.2016.113 ↗
2. Prediction of resistance to chemotherapy in ovarian cancer: a systematic review10.1186/s12885-015-1101-8 ↗
3. Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer10.18632/oncotarget.3814 ↗
4. Photochemical internalization (PCI): a technology for drug delivery10.1007/978-1-60761-697-9_10 ↗
5. Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation10.1002/ijc.29510 ↗
6. Photochemical activation of drugs for the treatment of therapy-resistant cancers10.1039/c5pp00029g ↗
7. Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease10.1021/acs.molpharmaceut.5b00426 ↗
8. Photochemical internalization-mediated delivery of chemotherapeutic agents in human breast tumor cell lines10.1615/JEnvironPatholToxicolOncol.v31.i1.60 ↗
9. Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines10.1038/s41598-017-06109-y ↗
10. Photochemical internalisation of a macromolecular protein toxin using a cell penetrating peptide-photosensitiser conjugate10.1016/j.jconrel.2011.08.025 ↗
11. Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial10.1016/S1470-2045(16)30224-8 ↗
12. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications10.1111/j.1365-2818.2005.01471.x ↗
13. Evaluation of physicochemical properties and aggregation of the photosensitizers TPCS2a and TPPS2a in aqueous media
14. Physicochemical characterization of the photosensitizers TPCS2a and TPPS2a 1. Spectroscopic evaluation of drug –solvent interactions
15. The molecular mechanism of photochemical internalization of cell penetrating peptide-cargo-photosensitizer conjugates10.1038/srep18577 ↗
16. Flexible synthesis of cationic peptide-porphyrin derivatives for light-triggered drug delivery and photodynamic therapy10.1039/C6OB02135B ↗
17. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug10.1016/j.jconrel.2012.02.003 ↗
18. Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance10.1016/j.bcp.2017.08.002 ↗
19. Saporin as a novel suicide gene in anticancer gene therapy10.1038/sj.cgt.7700998 ↗
20. Saporin-S6: a useful tool in cancer therapy10.3390/toxins5101698 ↗
21. Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: an in vitro study in 2D and 3D prostate cancer models10.1016/j.canlet.2017.02.018 ↗
22. Three-dimensional cell culture: a breakthrough in vivo10.3390/ijms16035517 ↗
23. Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture10.1016/j.jbiosc.2014.01.008 ↗
24. Microfluidic 3D cell culture: from tools to tissue models10.1016/j.copbio.2015.05.002 ↗
25. From 3D cell culture to organs-on-chips10.1016/j.tcb.2011.09.005 ↗
26. Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug10.1021/mp300595a ↗
27. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models10.1038/srep03751 ↗
28. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment10.1038/nrc.2015.3 ↗
29. A 3D In Vitro Cancer Model as a Platform for Nanoparticle Uptake and Imaging Investigations10.1002/smll.201400194 ↗
30. 3D tumour models: novel in vitro approaches to cancer studies10.1007/s12079-011-0132-4 ↗
31. Photodynamic therapy in 3D cancer models and the utilisation of nanodelivery systems10.1039/C7NR07739D ↗
32. Rapid Fabrication of Living Tissue Models by Collagen Plastic Compression: Understanding Three-Dimensional Cell Matrix Repair In Vitro10.1089/wound.2012.0392 ↗
33. Ultrarapid Engineering of Biomimetic Materials and Tissues: Fabrication of Nano- and Microstructures by Plastic Compression10.1002/adfm.200500042 ↗
34. Oxygen diffusion through collagen scaffolds at defined densities: implications for cell survival in tissue models10.1002/term.402 ↗
35. Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?10.1016/j.ijpharm.2017.05.071 ↗
36. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer10.1016/j.ymthe.2004.08.013 ↗
37. The efficacy of cetuximab in a tissue-engineered three-dimensional in vitro model of colorectal cancer10.1177/2041731414544183 ↗
38. Engineering a vascularised 3D in vitro model of cancer progression10.1038/srep44045 ↗
39. Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells
40. Photochemical internalization of bleomycin for glioma treatment10.1117/1.JBO.17.5.058001 ↗
41. Efficacy of DOPE/DC-cholesterol liposomes and GCPQ micelles as AZD6244 nanocarriers in a 3D colorectal cancer in vitro model10.2217/nnm.15.206 ↗
42. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro10.1038/labinvest.2013.41 ↗
43. Cytosolic delivery of liposomally targeted proteins induced by photochemical internalization10.1007/s11095-007-9338-9 ↗
44. Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model10.1038/sj.bjc.6605197 ↗
45. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential10.1038/sj.bjc.6604978 ↗
46. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells10.1038/sj.leu.2402419 ↗
47. Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel10.1371/journal.pone.0006691 ↗
48. Major determinants of photoinduced cell death: subcellular localization versus photosensitization efficiency10.1016/j.freeradbiomed.2011.05.023 ↗
49. Mitochondrial photodamage and PDT-induced apoptosis10.1016/S1011-1344(97)00127-9 ↗
50. Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview10.3390/cancers3011014 ↗
51. Ribosome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition10.1016/j.biocel.2008.06.004 ↗
52. Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses10.1371/journal.pone.0182930 ↗
53. The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model10.1371/journal.pone.0168389 ↗
54. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT10.1371/journal.pone.0023434 ↗
55. Toward a 3D cellular model for studying in vitro the outcome of photodynamic treatments: accounting for the effects of tissue complexity10.1089/ten.tea.2012.0661 ↗
56. The Resazurin Reduction Assay Can Distinguish Cytotoxic from Cytostatic Compounds in Spheroid Screening Assays
57. The challenge to measure cell proliferation in two and three dimensions10.1089/ten.2005.11.182 ↗
58. Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model10.1039/C4LC01065E ↗
59. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids10.1016/j.jphotobiol.2016.05.011 ↗
60. The alteration of temoporfin distribution in multicellular tumor spheroids by beta-cyclodextrins10.1016/j.ijpharm.2017.07.037 ↗
61. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models10.1038/s41598-017-12049-4 ↗
62. Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model10.1007/s00018-007-7356-8 ↗
63. Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapy10.1111/php.12027 ↗
64. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells
65. Photodynamic modification of disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line10.1039/b708456k ↗
66. Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin–quantitative studies in normal rat liver10.1016/j.jconrel.2009.11.017 ↗
67. Delivery of Amonafide from Fructose-Coated Nanodiamonds by Oxime Ligation for the Treatment of Human Breast Cancer10.1021/acs.biomac.7b01592 ↗
68. Comparison of nanomedicine-based chemotherapy, photodynamic therapy and photothermal therapy using reduced graphene oxide for the model system10.1039/C6BM00526H ↗
69. Image-guided surgery in gynecologic oncology10.2217/fon-2017-0253 ↗
70. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin10.1016/j.jconrel.2005.12.002 ↗
71. The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle10.3389/fonc.2015.00245 ↗